Merck Sharp & Dohme’s quadrivalent human papillomavirus (HPV) vaccine has become the first jab against the virus approved for use on men in China, the U.S. pharmaceutical giant said Wednesday. The China National Medi...
A recent study has found that China's first self-developed HPV vaccine Cecolin can offer female adults full immunity against two types of human papillomavirus (HPV). A group of Chinese researchers analyzed data from 66-month follow-up visits as a part of the bivalent vaccine's Phase 3 clinic...
US pharmaceutical company Merck & Co said on Wednesday that its four-valent human papillomavirus vaccine has been approved for men aged 9 to 26 by China's top drug regulator. The vaccine that protects against four HPV strains is the first shot for males on the Chinese mainland. ...
US pharmaceutical company Merck & Co said on Wednesday that its four-valent human papillomavirus vaccine has been approved for men aged 9 to 26 by China's top drug regulator. The vaccine that protects against four HPV strains is the first shot for males on the Chinese mainland. It was ...
A recent study has found that China's first self-developed HPV vaccine Cecolin can offer female adults full immunity against two types of human papillomavirus (HPV). A group of Chinese researchers analyzed data from 66-month follow-up visits as a part of the bivalent vaccine's Phase 3 clinic...
Merck Sharp & Dohme’s quadrivalent human papillomavirus (HPV) vaccine has become the first jab against the virus approved for use on men in China, the U.S. pharmaceutical giant said Wednesday. The China National Medical Products Administration has approved several new indications for Gardasil, inc...
BEIJING, Jan. 2 (Xinhua) -- China has approved the first domestically produced vaccine against the cancerogenic human papillomavirus (HPV), according to the National Medical Products Administration (NMPA). The domestically made vaccine is designed for use by females from the age of 9 to 45 and...
Another HPV vaccine developed by Xiamen University covering nine HPV types will undergo a phase three clinical trial, the last test before reaching the market, the university source noted. Last year, the university announced that it had made a breakthrough in developing a new-generation vaccine th...
China approves first HPV vaccine for men MERCK Sharp & Dohme’s quadrivalent human papillomavirus (HPV) vaccine has become the first jab against the virus approved for use on men in China, the U.S. pharmaceutical giant said Wednesday.
China's first domestically produced vaccine against the cancerogenic human papillomavirus (HPV) will be available by appointment from May, making China the third country in the world to achieve an independent HPV vaccine supply after the U.S. and the UK. ...